In support of these claims, the applicant provided two retrospective reviews (Lee et al., 2022 and Muscarella, 2022) of medical device reports (MDRs) from the FDA Manufacturer and User Facility Device Experience (MAUDE) database, an FDA News Release (2021, April 1) concerning infection and contamination risks associated with reusable urological endoscopes, and an FDA Update (2025, January 31) communicating the recall of endoscope accessories from Olympus reusable urological endoscopes as supporting evidence
Carroll RC, Beattie EC, von Zastrow M, Malenka RC (2001)
Fatty Liver Disease: Excess fat accumulation in the liver, known as non-alcoholic fatty liver disease (NAFLD), is commonly associated with obesity and metabolic syndrome
I wanted a protocol
PMC 3061630
For researchers studying peptides in clinical trials or performance studies, it is important to understand when to use advanced peptide testing